| dc.creator |
Yalcin, Suayip |
|
| dc.creator |
Turha, Nazim Serdar |
|
| dc.creator |
Bozcuk, Hakan |
|
| dc.creator |
Kocer, Murat |
|
| dc.creator |
KARABULUT, BÜLENT |
|
| dc.creator |
ARTAÇ, MEHMET |
|
| dc.creator |
Isik, Nalan |
|
| dc.creator |
Uygunl, Kazinn |
|
| dc.creator |
KARAAĞAÇ, MUSTAFA |
|
| dc.creator |
Gunduz, Seyda |
|
| dc.date |
2014-02-28T22:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:33:14Z |
|
| dc.date.available |
2020-10-06T10:33:14Z |
|
| dc.identifier |
7ad6290d-92b6-4329-9f34-22e4ea516874 |
|
| dc.identifier |
10.1700/1491.16397 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/7ad6290d-92b6-4329-9f34-22e4ea516874/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/64151 |
|
| dc.description |
Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study |
|
| dc.type |
info:eu-repo/semantics/article |
|